“Patients’ Quality of Life in a Phase 4 Real-World Study of Tildrakizumab in Moderate-to-Severe Plaque Psoriasis”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s135. Accessed November 7, 2025. https://skin.dermsquared.com/skin/article/view/2006.